COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – Science Direct

Post author By EvidenceNotFear
Post date 28 December 2020

First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease.

Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.

Significantly reduced hospitalisation rates in the treatment group.

Reduced mortality rates in the treatment group.

https://web.archive.org/web/20201117161908/https://www.sciencedirect.com/science/article/pii/S0924857920304258

Tags Azithromycin, COVID-19, Dr. Vladimir Zelenko, Hydroxychloroquine, Mortality Rate, Science Direct, Treatment, Zinc

Info This site is a curated archive of articles with a link to the source. Keywords and topics covered in the publication can be found above. Click on the tag to view a listing of similar articles.
Links Are any links broken? The page may have been taken down. Visit archive.is or archive.org to view the archive snapshot.
Links Help fight censorship and preserve information on the internet. Archive this source and links on archive.is and archive.org. Save a local copy on your own hard drive.